The AngioSculpt Scoring Balloon Catheter significantly alters the landscape for treating both peripheral arterial disease (PAD) and coronary artery disease (CAD). The innovative nitinol scoring element scores the plaque circumferentially, providing a precise and predictable dilatation across a wide range of lesion types. AngioSculpt provides the versatility and effectiveness of a new technology together with the simplicity and deliverability of a high-performance balloon catheter.

Caution: Federal law (USA) restricts the AngioSculpt Scoring Balloon Catheter to sale by or on the order of a physician.
CE Mark Granted for Coronary and Peripheral Applications.

Last Updated: October 31, 2007

May 13-16, 2008
EuroPCR 2008
Barcelona, SP

June 5-8, 2008
Society for Vascular Surgery
San Diego, CA

June 9-11, 2008
Capital Cardiovascular Conference
Balitmore, MD

05-01-08
AngioScore Receives FDA Clearance to Market AngioSculpt PTA Scoring Balloon Catheter for Additional Peripheral Indications

01-28-08
AngioScore Obtains Japanese Approval for AngioSculpt Scoring Balloon Catheter

10-09-07
AngioScore Announces Completion of $30 Million Financing